Evidence map›Paper›PMID 40240809›Full record

ArticleScientific reports2025

A multimodal MRI-based machine learning framework for classifying cognitive impairment in cerebral small vessel disease.

Guihan Lin, Weiyue Chen, Yongkang Geng, Bo Peng, Surui Liu, Minjiang Chen, Chunying Pang, Pengjun Chen, Chenying Lu, Zhihan Yan and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. [Progress on prognostic assessment methods for mild cognitive impairment].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Guihan Lin *Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Csaenter of Interventional Medicine Engineering and Biotechnology, Key Laboratory of Precision Medicine of Lishui City, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, 323000, Zhejiang, China.
Weiyue Chen *Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Csaenter of Interventional Medicine Engineering and Biotechnology, Key Laboratory of Precision Medicine of Lishui City, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, 323000, Zhejiang, China.
Yongkang Geng *School of Life Science and Technology, Changchun University of Science and Technology, Changchun, 130000, China.
Bo PengSuzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China.
Surui LiuSuzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China.
Minjiang ChenZhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Csaenter of Interventional Medicine Engineering and Biotechnology, Key Laboratory of Precision Medicine of Lishui City, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, 323000, Zhejiang, China.
Chunying PangSchool of Life Science and Technology, Changchun University of Science and Technology, Changchun, 130000, China.
Pengjun ChenZhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Csaenter of Interventional Medicine Engineering and Biotechnology, Key Laboratory of Precision Medicine of Lishui City, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, 323000, Zhejiang, China.
Chenying LuZhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Csaenter of Interventional Medicine Engineering and Biotechnology, Key Laboratory of Precision Medicine of Lishui City, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, 323000, Zhejiang, China.
Zhihan YanWenzhou Key Laboratory of Structural and Functional Imaging, Wenzhou, 325000, China.
Shuiwei XiaZhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Csaenter of Interventional Medicine Engineering and Biotechnology, Key Laboratory of Precision Medicine of Lishui City, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, 323000, Zhejiang, China.
Yakang DaiSuzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China. daiyk@sibet.ac.cn.
Jiansong JiZhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Csaenter of Interventional Medicine Engineering and Biotechnology, Key Laboratory of Precision Medicine of Lishui City, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, 323000, Zhejiang, China. jjstcty@wmu.edu.cn.

Funding

Zhejiang Provincial Healthcare Program 2024KY562Zhejiang Public Welfare Research Program LGF19H180010Zhejiang Public Welfare Research Program LGF20H220002
6 · The paper itself

Abstract

The heterogeneity of cerebral small vessel disease (CSVD) with mild cognitive impairment (MCI) presents a challenge for diagnosis and classification. This study aims to propose a multimodal magnetic resonance imaging (MRI)-based machine learning framework to effectively classify MCI and NCI in CSVD patients. We enrolled 165 CSVD patients, categorized into NCI (n = 81) and MCI (n = 84) groups based on neurocognitive assessments. Multimodal MRI data, including T1-weighted, resting-state functional MRI, and diffusion tensor images, were collected. Image preprocessing, feature extraction and selection were applied to obtain MRI features from three modalities. The AutoGluon platform was utilized for model development, and traditional machine learning algorithms were applied for comparison. The models were validated using a validation cohort of 83 CSVD patients, and their performance was assessed via receiver operating characteristic curve analysis. The AutoGluon model to distinguish MCI from NCI based on multimodal MRI features demonstrated high area under the curve (AUC), accuracy, sensitivity, specificity, precision, balanced accuracy, and F1-score in the training cohort (0.926, 88.48%, 88.10%, 88.89%, 89.16%, 88.50%, and 88.63%, respectively) and validation cohort (0.878, 81.93%, 86.36%, 76.92%, 80.85%, 81.64%, and 83.51%, respectively). Other traditional machine learning models had AUCs of 0.755-0.831, and their prediction accuracies were significantly lower than that of AutoGluon model (P < 0.001). Our study provides a multimodal MRI-based machine learning framework, utilizing the AutoGluon platform, that outperforms traditional algorithms in classifying MCI and NCI, offering a promising tool for the early prediction of MCI in CSVD.

Indexed as

Cerebral Small Vessel DiseasesCognitive DysfunctionMachine LearningMagnetic Resonance ImagingMultimodal ImagingAgedAlgorithmsDiffusion Tensor ImagingFemaleHumansMaleMiddle AgedROC CurveAutoGluonCerebral small vessel diseaseCognitive impairmentMachine learningMultimodal MRI

Identifiers

PMID40240809
PMCPMC12003736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.